Literature DB >> 11875052

SRp30c-dependent stimulation of survival motor neuron (SMN) exon 7 inclusion is facilitated by a direct interaction with hTra2 beta 1.

Philip J Young1, Christine J DiDonato, Diane Hu, Rashmi Kothary, Elliot J Androphy, Christian L Lorson.   

Abstract

Proximal spinal muscular atrophy (SMA) is caused by the homozygous loss of survival motor neuron (SMN1). SMN2, a nearly identical copy gene, is present in all SMA patients; however this gene cannot provide protection from disease due to the aberrant splicing of a critical exon. SMN1-derived transcripts are exclusively full-length, whereas SMN2-derived transcripts predominantly lack SMN exon 7. A single non-polymorphic nucleotide difference (C in SMN1; T in SMN2) is responsible for the alternative splicing patterns. We have previously shown that transient expression of an SR-like splicing factor, hTra2 beta 1, stimulates inclusion of exon 7 in SMN2-derived mini-gene transcripts through an interaction with the AG-rich exonic splice enhancer within exon 7. We now demonstrate that a second splicing factor, SRp30c, can stimulate SMN exon 7-inclusion and that this activity required the same AG-rich enhancer as hTra2 beta 1. SRp30c did not directly associate with SMN exon 7; rather its association with the exonic enhancer was mediated by a direct interaction with hTra2 beta 1. In the absence of the hTra2 beta 1 binding site, SRp30c failed to complex with SMN exon 7. Taken together, these results identify SRp30c as a modulator of SMN exon 7-inclusion and provide insight into the molecular regulation of this critical exon.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11875052     DOI: 10.1093/hmg/11.5.577

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  62 in total

1.  In vivo selection reveals combinatorial controls that define a critical exon in the spinal muscular atrophy genes.

Authors:  Natalia N Singh; Elliot J Androphy; Ravindra N Singh
Journal:  RNA       Date:  2004-08       Impact factor: 4.942

2.  Splicing regulation in spinal muscular atrophy by an RNA structure formed by long-distance interactions.

Authors:  Natalia N Singh; Brian M Lee; Ravindra N Singh
Journal:  Ann N Y Acad Sci       Date:  2015-02-27       Impact factor: 5.691

3.  SRp54 (SFRS11), a regulator for tau exon 10 alternative splicing identified by an expression cloning strategy.

Authors:  Jane Y Wu; Amar Kar; David Kuo; Bing Yu; Necat Havlioglu
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

4.  The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells.

Authors:  Markus Riessland; Lars Brichta; Eric Hahnen; Brunhilde Wirth
Journal:  Hum Genet       Date:  2006-05-25       Impact factor: 4.132

5.  Molecular basis of purine-rich RNA recognition by the human SR-like protein Tra2-β1.

Authors:  Antoine Cléry; Sandrine Jayne; Natalya Benderska; Cyril Dominguez; Stefan Stamm; Frédéric H-T Allain
Journal:  Nat Struct Mol Biol       Date:  2011-03-13       Impact factor: 15.369

6.  High-throughput analysis revealed mutations' diverging effects on SMN1 exon 7 splicing.

Authors:  Přemysl Souček; Kamila Réblová; Michal Kramárek; Lenka Radová; Tereza Grymová; Pavla Hujová; Tatiana Kováčová; Matej Lexa; Lucie Grodecká; Tomáš Freiberger
Journal:  RNA Biol       Date:  2019-06-19       Impact factor: 4.652

7.  Optimization of Morpholino Antisense Oligonucleotides Targeting the Intronic Repressor Element1 in Spinal Muscular Atrophy.

Authors:  Erkan Y Osman; Charles W Washington; Kevin A Kaifer; Chiara Mazzasette; Teresa N Patitucci; Kyra M Florea; Madeline E Simon; Chien-Ping Ko; Allison D Ebert; Christian L Lorson
Journal:  Mol Ther       Date:  2016-07-09       Impact factor: 11.454

8.  A feedback loop regulates splicing of the spinal muscular atrophy-modifying gene, SMN2.

Authors:  Francine M Jodelka; Allison D Ebert; Dominik M Duelli; Michelle L Hastings
Journal:  Hum Mol Genet       Date:  2010-09-30       Impact factor: 6.150

Review 9.  SMN regulation in SMA and in response to stress: new paradigms and therapeutic possibilities.

Authors:  Catherine E Dominguez; David Cunningham; Dawn S Chandler
Journal:  Hum Genet       Date:  2017-08-29       Impact factor: 4.132

Review 10.  SMN-inducing compounds for the treatment of spinal muscular atrophy.

Authors:  Monique A Lorson; Christian L Lorson
Journal:  Future Med Chem       Date:  2012-10       Impact factor: 3.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.